Marinus Pharmaceuticals, Inc.

170 N Radnor Chester Road
United States

Tel: 484-801-4674

Show jobs for this employer

About Marinus Pharmaceuticals, Inc.

Marinus Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company dedicated to improving the lives of patients; women suffering from postpartum depression; children suffering from drug-resistant epilepsies such as CDKL5 deficiency disorder (a serious, rare genetic epilepsy), and rare behavior disorders, such as FXS (Fragile X Syndrome).    

We are developing Ganaxolone in three different dose forms (IV, capsule and liquid) intended to maximize therapeutic reach to adult and pediatric patient populations in both acute and chronic care settings. Marinus is preparing to initiate a pivotal study in children with rare, CDKL5 deficiency disorder and currently conducting studies in postpartum depression and refractory status epilepticus. 

Our team is determined to bring these drugs to the patients who need them; and improve their quality of life and the quality of life for their loved ones.  We are seeking team members who want to be part of a dynamic and cohesive team ready use his/her talents to their full potential.  

Stock Symbol: MRNS

Stock Exchange: Nasdaq

123 articles with Marinus Pharmaceuticals, Inc.